ABCELLERA BIOLOGICS INC (ABCL:NASDAQ)
$12.83 0.75 (6.2086%)
Analysed ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) News Sources
AbCellera Biologics (ABCL) Could Be 33% Overvalued Following ABCL635 Phase 2 Results
11-08-2026
yahoo.com
AbCellera Biologics (ABCL) Stock Sees Fair Value Lift After Clinical Data And Jazz Deal
12-08-2026
yahoo.com
AbCellera Biologics (ABCL) Is Up 60.3% After Strong Phase 2 Menopause Data For ABCL635 - Has The Bull Case Changed?
12-08-2026
yahoo.com
AbCellera (ABCL) Q2 2026 Earnings Call Transcript
13-08-2026
fool.com
Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough?
14-08-2026
yahoo.com
AbCellera Announces Presentation of Phase 2 Data for ABCL635 at the IMS World Congress on Menopause 2026
16-09-2026
yahoo.com
AbCellera to Report Third Quarter 2026 Financial Results on November 9, 2026
01-10-2026
yahoo.com
AbCellera Announces Presentation of Phase 1/2 Data for ABCL635 at TMS 2026 Annual Meeting
08-10-2026
yahoo.com
AbCellera Biologics (ABCL) Could Be 27% Undervalued As ABCL635 Data Draws Focus
09-10-2026
yahoo.com
AbCellera to Present at Upcoming Investor Conferences in November 2026
22-10-2026
yahoo.com
What is the current price of ABCELLERA BIOLOGICS INC (ABCL:NASDAQ)?
The current price of ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) is $12.83.
ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) absolute price change since previous trading day?
The absolute price change of ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) since the previous trading day is $0.75.
ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) percentage price change since previous trading day?
The percentage price change of ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) since the previous trading day is 6.2086%.
What is the most recent average sentiment score for ABCELLERA BIOLOGICS INC (ABCL:NASDAQ)?
The most recent average sentiment score for ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) is 66 out of 100.
What is the most recent average sentiment for ABCELLERA BIOLOGICS INC (ABCL:NASDAQ)?
The most recent sentiment for ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) is .
SEC-8K** Filing Available For ABCELLERA BIOLOGICS INC (ABCL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.